- Report
- February 2024
- 78 Pages
Global
From €3405EUR$3,500USD£2,917GBP
- Report
- April 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 250 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- January 2024
- 200 Pages
Global
From €3892EUR$4,000USD£3,334GBP
- Report
- January 2024
- 200 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- January 2024
- 200 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- March 2024
- 189 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- March 2024
- 197 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- March 2024
- 188 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- March 2024
- 183 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- March 2024
- 198 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- July 2023
- 220 Pages
Global
From €1936EUR$1,990USD£1,659GBP
- Report
- April 2024
- 93 Pages
Global
From €5449EUR$5,600USD£4,668GBP
- Report
- April 2024
- 93 Pages
Global
From €5449EUR$5,600USD£4,668GBP
- Report
- April 2024
- 94 Pages
Global
From €5449EUR$5,600USD£4,668GBP
- Report
- April 2024
- 196 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- May 2023
- 148 Pages
Global
From €2431EUR$2,499USD£2,083GBP
- Report
- January 2024
- 149 Pages
Global
From €3794EUR$3,899USD£3,250GBP
- Report
- November 2023
- 141 Pages
Global
From €2431EUR$2,499USD£2,083GBP
The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more